Παρασκευή 19 Ιανουαρίου 2018

Impact of doxorubicin dose capping on the outcome of DLBCL patients with elevated body surface area.

http:--highwire.stanford.edu-icons-exter Related Articles

Impact of doxorubicin dose capping on the outcome of DLBCL patients with elevated body surface area.

Blood. 2017 05 18;129(20):2811-2813

Authors: Gay C, Delarue R, Milpied N, Oberic L, Coiffier B, Boussetta S, Haioun C, Tilly H, Salles G, Lamy T, Lester MA, Houot R

PMID: 28302615 [PubMed - indexed for MEDLINE]



http://ift.tt/2mTvBoj

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου